Demonstrated benefits on intestinal health New research from the University of Tartu, Estonia, and the National Research Council, Italy, have shown beneficial effects of ME-3 on gut microbiota composition and reduction of intestinal permeability
Ozempic, also known as semaglutide, is among a host of GLP-1 agonists that researchers are exploring and the FDA is approving for the treatment of diabetes, obesity, cardiovascular risk reduction, weight management, and perhaps chronic kidney disease
It can also interfere with your weight loss goals, so its best to limit your intake and pay close attention to how your body reacts
Whether you possess a smartphone, tablet, or computer, our Columbus healthcare team empowers you by efficiently managing insurance, authorizations, and care coordination